Biological drugs are also called macromolecular drugs. Biological products are mainly divided into therapeutic biological drugs and preventive biological drugs. Preventive biological drugs mainly refer to vaccines. Therapeutic biological drugs mainly include monoclonal antibodies, enzymes, interferons, cytokines and insulin.
The global Macromolecule Biopharmaceuticals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Macromolecule Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Macromolecule Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Macromolecule Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Macromolecule Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macromolecule Biopharmaceuticals.
Report Scope
The Macromolecule Biopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Macromolecule Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macromolecule Biopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3SBio
Changchun High-tech
CITIC Guojian
Baitai Biology
Saijin Biotechnology
Innovent
Tonghua Dongbao
Gan Li
United Pharmaceuticals
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira (Pfizer)
MYLAN
Sun Pharma
Segment by Type
Biological Drugs
Biosimilars
Segment by Application
Cancer
Diabetic
Cardiovascular
Hemophilia
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Macromolecule Biopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Macromolecule Biopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Macromolecule Biopharmaceuticals 麻豆原创 Overview
1.1 Product Overview and Scope of Macromolecule Biopharmaceuticals
1.2 Macromolecule Biopharmaceuticals Segment by Type
1.2.1 Global Macromolecule Biopharmaceuticals 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Biological Drugs
1.2.3 Biosimilars
1.3 Macromolecule Biopharmaceuticals Segment by Application
1.3.1 Global Macromolecule Biopharmaceuticals 麻豆原创 Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Diabetic
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Macromolecule Biopharmaceuticals 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Macromolecule Biopharmaceuticals Revenue 2019-2030
1.4.2 Global Macromolecule Biopharmaceuticals Sales 2019-2030
1.4.3 Global Macromolecule Biopharmaceuticals 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Macromolecule Biopharmaceuticals 麻豆原创 Competition by Manufacturers
2.1 Global Macromolecule Biopharmaceuticals Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Macromolecule Biopharmaceuticals Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Macromolecule Biopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Macromolecule Biopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Macromolecule Biopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Macromolecule Biopharmaceuticals, Product Type & Application
2.7 Macromolecule Biopharmaceuticals 麻豆原创 Competitive Situation and Trends
2.7.1 Macromolecule Biopharmaceuticals 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Macromolecule Biopharmaceuticals Players 麻豆原创 Share by Revenue
2.7.3 Global Macromolecule Biopharmaceuticals 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Macromolecule Biopharmaceuticals Retrospective 麻豆原创 Scenario by Region
3.1 Global Macromolecule Biopharmaceuticals 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Macromolecule Biopharmaceuticals Global Macromolecule Biopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Macromolecule Biopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Macromolecule Biopharmaceuticals Sales by Region: 2025-2030
3.3 Global Macromolecule Biopharmaceuticals Global Macromolecule Biopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Macromolecule Biopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Macromolecule Biopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Macromolecule Biopharmaceuticals 麻豆原创 Facts & Figures by Country
3.4.1 North America Macromolecule Biopharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Macromolecule Biopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Macromolecule Biopharmaceuticals Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Macromolecule Biopharmaceuticals 麻豆原创 Facts & Figures by Country
3.5.1 Europe Macromolecule Biopharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Macromolecule Biopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Macromolecule Biopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Macromolecule Biopharmaceuticals 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Macromolecule Biopharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Macromolecule Biopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Macromolecule Biopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Macromolecule Biopharmaceuticals 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Macromolecule Biopharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Macromolecule Biopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Macromolecule Biopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Macromolecule Biopharmaceuticals 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Macromolecule Biopharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Macromolecule Biopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Macromolecule Biopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Macromolecule Biopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Macromolecule Biopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Macromolecule Biopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Macromolecule Biopharmaceuticals Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Macromolecule Biopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Macromolecule Biopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Macromolecule Biopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Macromolecule Biopharmaceuticals Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Macromolecule Biopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Macromolecule Biopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Macromolecule Biopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Macromolecule Biopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Macromolecule Biopharmaceuticals Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Macromolecule Biopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Macromolecule Biopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Macromolecule Biopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Macromolecule Biopharmaceuticals Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Macromolecule Biopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Macromolecule Biopharmaceuticals Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Macromolecule Biopharmaceuticals Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Macromolecule Biopharmaceuticals Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Sanofi-Aventis
6.4.1 Sanofi-Aventis Corporation Information
6.4.2 Sanofi-Aventis Description and Business Overview
6.4.3 Sanofi-Aventis Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi-Aventis Macromolecule Biopharmaceuticals Product Portfolio
6.4.5 Sanofi-Aventis Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Macromolecule Biopharmaceuticals Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Macromolecule Biopharmaceuticals Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Macromolecule Biopharmaceuticals Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly Macromolecule Biopharmaceuticals Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis Macromolecule Biopharmaceuticals Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Merck
6.10.1 Merck Corporation Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merck Macromolecule Biopharmaceuticals Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Sun
6.11.1 Sun Corporation Information
6.11.2 Sun Macromolecule Biopharmaceuticals Description and Business Overview
6.11.3 Sun Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Macromolecule Biopharmaceuticals Product Portfolio
6.11.5 Sun Recent Developments/Updates
6.12 3SBio
6.12.1 3SBio Corporation Information
6.12.2 3SBio Macromolecule Biopharmaceuticals Description and Business Overview
6.12.3 3SBio Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.12.4 3SBio Macromolecule Biopharmaceuticals Product Portfolio
6.12.5 3SBio Recent Developments/Updates
6.13 Changchun High-tech
6.13.1 Changchun High-tech Corporation Information
6.13.2 Changchun High-tech Macromolecule Biopharmaceuticals Description and Business Overview
6.13.3 Changchun High-tech Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Changchun High-tech Macromolecule Biopharmaceuticals Product Portfolio
6.13.5 Changchun High-tech Recent Developments/Updates
6.14 CITIC Guojian
6.14.1 CITIC Guojian Corporation Information
6.14.2 CITIC Guojian Macromolecule Biopharmaceuticals Description and Business Overview
6.14.3 CITIC Guojian Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CITIC Guojian Macromolecule Biopharmaceuticals Product Portfolio
6.14.5 CITIC Guojian Recent Developments/Updates
6.15 Baitai Biology
6.15.1 Baitai Biology Corporation Information
6.15.2 Baitai Biology Macromolecule Biopharmaceuticals Description and Business Overview
6.15.3 Baitai Biology Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Baitai Biology Macromolecule Biopharmaceuticals Product Portfolio
6.15.5 Baitai Biology Recent Developments/Updates
6.16 Saijin Biotechnology
6.16.1 Saijin Biotechnology Corporation Information
6.16.2 Saijin Biotechnology Macromolecule Biopharmaceuticals Description and Business Overview
6.16.3 Saijin Biotechnology Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Saijin Biotechnology Macromolecule Biopharmaceuticals Product Portfolio
6.16.5 Saijin Biotechnology Recent Developments/Updates
6.17 Innovent
6.17.1 Innovent Corporation Information
6.17.2 Innovent Macromolecule Biopharmaceuticals Description and Business Overview
6.17.3 Innovent Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Innovent Macromolecule Biopharmaceuticals Product Portfolio
6.17.5 Innovent Recent Developments/Updates
6.18 Tonghua Dongbao
6.18.1 Tonghua Dongbao Corporation Information
6.18.2 Tonghua Dongbao Macromolecule Biopharmaceuticals Description and Business Overview
6.18.3 Tonghua Dongbao Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Tonghua Dongbao Macromolecule Biopharmaceuticals Product Portfolio
6.18.5 Tonghua Dongbao Recent Developments/Updates
6.19 Gan Li
6.19.1 Gan Li Corporation Information
6.19.2 Gan Li Macromolecule Biopharmaceuticals Description and Business Overview
6.19.3 Gan Li Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Gan Li Macromolecule Biopharmaceuticals Product Portfolio
6.19.5 Gan Li Recent Developments/Updates
6.20 United Pharmaceuticals
6.20.1 United Pharmaceuticals Corporation Information
6.20.2 United Pharmaceuticals Macromolecule Biopharmaceuticals Description and Business Overview
6.20.3 United Pharmaceuticals Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.20.4 United Pharmaceuticals Macromolecule Biopharmaceuticals Product Portfolio
6.20.5 United Pharmaceuticals Recent Developments/Updates
6.21 SANDOZ (NOVARTIS)
6.21.1 SANDOZ (NOVARTIS) Corporation Information
6.21.2 SANDOZ (NOVARTIS) Macromolecule Biopharmaceuticals Description and Business Overview
6.21.3 SANDOZ (NOVARTIS) Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.21.4 SANDOZ (NOVARTIS) Macromolecule Biopharmaceuticals Product Portfolio
6.21.5 SANDOZ (NOVARTIS) Recent Developments/Updates
6.22 Teva Pharmaceutical
6.22.1 Teva Pharmaceutical Corporation Information
6.22.2 Teva Pharmaceutical Macromolecule Biopharmaceuticals Description and Business Overview
6.22.3 Teva Pharmaceutical Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Teva Pharmaceutical Macromolecule Biopharmaceuticals Product Portfolio
6.22.5 Teva Pharmaceutical Recent Developments/Updates
6.23 Hospira (Pfizer)
6.23.1 Hospira (Pfizer) Corporation Information
6.23.2 Hospira (Pfizer) Macromolecule Biopharmaceuticals Description and Business Overview
6.23.3 Hospira (Pfizer) Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Hospira (Pfizer) Macromolecule Biopharmaceuticals Product Portfolio
6.23.5 Hospira (Pfizer) Recent Developments/Updates
6.24 MYLAN
6.24.1 MYLAN Corporation Information
6.24.2 MYLAN Macromolecule Biopharmaceuticals Description and Business Overview
6.24.3 MYLAN Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.24.4 MYLAN Macromolecule Biopharmaceuticals Product Portfolio
6.24.5 MYLAN Recent Developments/Updates
6.25 Sun Pharma
6.25.1 Sun Pharma Corporation Information
6.25.2 Sun Pharma Macromolecule Biopharmaceuticals Description and Business Overview
6.25.3 Sun Pharma Macromolecule Biopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Sun Pharma Macromolecule Biopharmaceuticals Product Portfolio
6.25.5 Sun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Macromolecule Biopharmaceuticals Industry Chain Analysis
7.2 Macromolecule Biopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Macromolecule Biopharmaceuticals Production Mode & Process
7.4 Macromolecule Biopharmaceuticals Sales and 麻豆原创ing
7.4.1 Macromolecule Biopharmaceuticals Sales Channels
7.4.2 Macromolecule Biopharmaceuticals Distributors
7.5 Macromolecule Biopharmaceuticals Customers
8 Macromolecule Biopharmaceuticals 麻豆原创 Dynamics
8.1 Macromolecule Biopharmaceuticals Industry Trends
8.2 Macromolecule Biopharmaceuticals 麻豆原创 Drivers
8.3 Macromolecule Biopharmaceuticals 麻豆原创 Challenges
8.4 Macromolecule Biopharmaceuticals 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3SBio
Changchun High-tech
CITIC Guojian
Baitai Biology
Saijin Biotechnology
Innovent
Tonghua Dongbao
Gan Li
United Pharmaceuticals
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira (Pfizer)
MYLAN
Sun Pharma
听
听
*If Applicable.